CD4 and COVID-19: Given the absence of significant compositional changes in the baseline naïve, effector, TCM and TEM subsets of CD3+CD4+ and CD3+CD8+ T cells, we then investigated the extent of functional differentiation within the convalescent COVID-19 immunome by stimulating the samples with PMA and ionomycin (Figure 2).